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Background
Human immunodeficiency virus (HIV) infection is associ-
ated with persistent generalized lymphadenopathy (PGL)
resulting from polyclonal B cell activation with significant
circulating Epstein-Barr virus (EBV). Does HHV-8 contrib-
ute to the hyperplasia when present? Unlike EBV, sero-
prevalence of HHV-8 in the HIV-negative U.S. population
is low. Kaposi's sarcoma (KS) in HIV infected is thought
to reflect "de novo" HHV-8 infection, not reactivation.
Does primary HHV-8 infection present as a polyclonal B
cell activation manifested as PGL such as other HHV-8
associated co-morbidities like primary effusion lym-
phoma and multicentric Castleman's disease? This study
examines the association of HHV-8 (LANA-1) with B cells
in HIV-associated PGLs.
Methods
HIV-positive serum samples from four women and 18
men (nine African-American, one African (woman) and
12 Caucasian) with available matching lymph nodes
(eight axillary, eight groin, two cervical, two mandible,
one supraclavicular, and one lung) constituted the study
set of 22 individuals. Serum samples were examined for
HHV-8 antibodies. The lymph nodes were examined his-
tologically for HHV-8 using LANA-1 immunohistochem-
istry (IHC) and EBV using EBER in situ hybridization
(ISH).
Results
Three sera had positive HHV-8 titers: 1). 1:1240 in a Cau-
casian man, age 28, with a 1.0 cm hyperplastic axillary
lymph node with prominent vascular proliferation and an
area in the capsule with HHV-8+ endothelial cells. No
LANA-1+ cells were present within the germinal centers or
paracortical areas. Clinical KS was present at the time of
the biopsy. 2). 1:640 in African woman, age 47, with a 2.2
cm axillary lymph node with giant follicular hyperplasia
showing many EBER+ cells in paracortical areas and focal
LANA-1 positive germinal center cells and few positive
paracortical plasma cells. Pleural lymphoma developed 6
months after this biopsy. 3). 1:320 in an African/Ameri-
can man, age 46, who had a 0.6 cm groin lymph node,
both LANA-1 and EBV negative. Neither lymphoma nor
KS developed during the following 7 years. Hyperplastic
lymph nodes from HHV-8 seronegative patients were
LANA-1 negative but EBER+ (13 of 19). EBV negative
nodes were small (0.6–0.3 cm), groin lymph nodes.
Conclusion
PGL is associated with EBV positive cells in the paracorti-
cal areas of hyperplastic lymph nodes. HIV-positive
patients with HHV-8 positive serology had large, medium,
and small lymph nodes. The HHV-8 seropositive African
woman's hyperplastic lymph node showed EBV(EBER)
positive cells in the paracortical regions and a few HHV-8
(LANA-1)+ B cells in the germinal centers and a few posi-
tive plasma cells in the paracortical areas demonstrating
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that HHV-8 can be present in B cells. Reactivation of
HHV-8 in the African woman with HIV is more likely than
"de novo" infection. Significant HHV-8 associated lymph
node hyperplasia in the absence of EBV appears uncom-
mon. PGL biospecimens are available from the AIDS and
Cancer Specimen Resource (ACSR) for further study.Page 2 of 2
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